Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency

Restoration of mutant cytochrome P450 reductase activity by external flavin

(2010) Catherine Nicolo et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19

(2010) Vishal Agrawal et al.   Pharmacogenetics and Genomics

The missing linkage: what pharmacogenetic associations are left to find inCYP3A?

(2009) Minoli A Perera   Expert Opinion on Drug Metabolism & Toxicology

Cholesterol Metabolism: the Main Pathway Acting Downstream of Cytochrome P450 Oxidoreductase in Skeletal Development of the Limb

(2009) K. Schmidt et al.   MOLECULAR AND CELLULAR BIOLOGY

The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test

(2009) Beatrice Oneda et al.   Pharmacogenetics and Genomics

Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation

(2009) Ana M Gomes et al.   PHARMACOGENOMICS

Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley–Bixler syndrome variants of cytochrome P450 oxidoreductase

(2008) Michel Kranendonk et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam

(2008) D. Tomalik-Scharte et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism

(2008) Steven N. Hart et al.   Pharmacogenetics and Genomics

Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations

(2008) N. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA